{
    "organizations": [],
    "uuid": "6a8484cd1c1da038140e3bc40e60603e288692be",
    "author": "",
    "url": "https://www.reuters.com/article/brief-helix-biopharma-to-explore-partner/brief-helix-biopharma-to-explore-partnership-joint-development-or-licensing-of-drug-idUSFWN1QC1C4",
    "ord_in_thread": 0,
    "title": "BRIEF-Helix Biopharma To Explore Partnership, Joint Development Or Licensing Of Drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Helix Biopharma Corp:\n* HELIX BIOPHARMA - BOARD AUTHORIZED PROCESS TO EXPLORE PARTNERSHIP, JOINT DEVELOPMENT OR LICENSING TRANSACTION OF COâ€˜S L-DOS47 DRUG PRODUCT CANDIDATE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T00:31:00.000+02:00",
    "crawled": "2018-02-23T00:54:20.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "helix",
        "biopharma",
        "corp",
        "helix",
        "biopharma",
        "board",
        "authorized",
        "process",
        "explore",
        "partnership",
        "joint",
        "development",
        "licensing",
        "transaction",
        "co",
        "drug",
        "product",
        "candidate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}